ABOS
Price
$2.13
Change
-$0.04 (-1.84%)
Updated
Jul 24 closing price
Capitalization
153.84M
22 days until earnings call
Intraday BUY SELL Signals
SKYE
Price
$0.65
Change
-$0.03 (-4.41%)
Updated
Jul 24 closing price
Capitalization
22.91M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABOS vs SKYE

ABOS vs SKYE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABOS vs. SKYE commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and SKYE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2026
Stock price -- (ABOS: $2.13 vs. SKYE: $0.65)
Brand notoriety: ABOS and SKYE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 28% vs. SKYE: 26%
Market capitalization -- ABOS: $153.84M vs. SKYE: $22.91M
ABOS [@Biotechnology] is valued at $153.84M. SKYE’s [@Biotechnology] market capitalization is $22.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileSKYE’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • SKYE’s FA Score: 0 green, 5 red.
According to our system of comparison, SKYE is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 3 TA indicator(s) are bullish while SKYE’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 3 bullish, 6 bearish.
  • SKYE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SKYE is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -5.33% price change this week, while SKYE (@Biotechnology) price change was +0.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.78%. For the same industry, the average monthly price growth was -3.76%, and the average quarterly price growth was +1901.89%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 17, 2026.

SKYE is expected to report earnings on Aug 07, 2026.

Industries' Descriptions

@Biotechnology (-4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABOS($154M) has a higher market cap than SKYE($22.9M). ABOS YTD gains are higher at: 0.948 vs. SKYE (-13.045). SKYE has higher annual earnings (EBITDA): -56.61M vs. ABOS (-108.82M). ABOS has more cash in the bank: 128M vs. SKYE (17.1M). SKYE has less debt than ABOS: SKYE (311K) vs ABOS (31.2M). ABOS (0) and SKYE (0) have equivalent revenues.
ABOSSKYEABOS / SKYE
Capitalization154M22.9M672%
EBITDA-108.82M-56.61M192%
Gain YTD0.948-13.045-7%
P/E RatioN/A3.57-
Revenue00-
Total Cash128M17.1M749%
Total Debt31.2M311K10,032%
FUNDAMENTALS RATINGS
SKYE: Fundamental Ratings
SKYE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSSKYE
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signal:
Gain/Loss:
SKYE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCKT9.710.41
+4.41%
Hackett Group
NAVN23.200.97
+4.36%
Navan Inc
EPC27.630.94
+3.52%
Edgewell Personal Care Company
IBN29.510.27
+0.92%
ICICI Bank Limited
BEEM1.01-0.08
-7.34%
Beam Global